WO2025190303 - SALT OF ARGININE-ARGININE DIPEPTIDE AND COMPOSITION
National phase entry is expected:
Publication Number
WO/2025/190303
Publication Date
18.09.2025
International Application No.
PCT/CN2025/081979
International Filing Date
12.03.2025
Title **
[English]
SALT OF ARGININE-ARGININE DIPEPTIDE AND COMPOSITION
[French]
SEL DE DIPEPTIDE ARGININE-ARGININE ET COMPOSITION
[Chinese]
精氨酸二肽的盐和组合物
Applicants **
NANJING ICD BIOTECHNOLOGY CO., LTD.
Inventors
ZHU, Jinjian
HOU, Shen
ZHU, Xi
LIAO, Qilin
Priority Data
PCT/CN2024/081641
14.03.2024
CN
PCT/CN2024/090510
29.04.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2150 | |
| EPO | Filing, Examination, Granting | 18293 | |
| Japan | Filing, Examination, Granting | 2574 | |
| South Korea | Filing, Examination, Granting | 2998 | |
| USA | Filing, Examination, Granting | 6340 |

Total:
32,355
Contact Us
Abstract[English]
Disclosed in the present invention are a physiologically acceptable salt of an arginine-arginine dipeptide and a preparation method therefor. Further disclosed is a composition containing the arginine-arginine dipeptide and the salt thereof, and arginine and a salt thereof. The method of the present invention can be used for efficient and stable production of the salt of the arginine-arginine dipeptide. The composition of the present invention does not require the separation of a small amount of arginine from the arginine-arginine dipeptide, and thus has great cost advantage and commercial potential regarding both synthesis and purification.[French]
La présente invention concerne un sel physiologiquement acceptable d'un dipeptide arginine-arginine et son procédé de préparation. L'invention concerne en outre une composition contenant le dipeptide arginine-arginine et son sel, et de l'arginine et son sel. Le procédé selon la présente invention peut être utilisé pour la production efficace et stable du sel du dipeptide arginine-arginine. La composition selon la présente invention ne nécessite pas la séparation d'une petite quantité d'arginine du dipeptide arginine-arginine, et présente ainsi une grande économie de coût et un potentiel commercial dans la synthèse et la purification.[Chinese]
本发明公开了精氨酸二肽的生理学上可接受的盐及其制备方法。还公开了一种组合物,包含精氨酸二肽及其盐;和精氨酸及其盐。本发明的方法可以高效且稳定地生产精氨酸二肽的盐。本发明的组合物无需分离精氨酸二肽和少量的精氨酸,在合成和纯化上都有极大的成本优势和商业化潜力。